Capricor Therapeutics (CAPR) Assets Average (2016 - 2025)
Historic Assets Average for Capricor Therapeutics (CAPR) over the last 17 years, with Q3 2025 value amounting to $130.0 million.
- Capricor Therapeutics' Assets Average rose 9813.23% to $130.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $130.0 million, marking a year-over-year increase of 9813.23%. This contributed to the annual value of $114.6 million for FY2024, which is 11061.93% up from last year.
- As of Q3 2025, Capricor Therapeutics' Assets Average stood at $130.0 million, which was up 9813.23% from $143.7 million recorded in Q2 2025.
- In the past 5 years, Capricor Therapeutics' Assets Average ranged from a high of $162.1 million in Q1 2025 and a low of $39.1 million during Q1 2021
- In the last 5 years, Capricor Therapeutics' Assets Average had a median value of $52.0 million in 2022 and averaged $68.9 million.
- In the last 5 years, Capricor Therapeutics' Assets Average tumbled by 2574.27% in 2023 and then surged by 22755.22% in 2025.
- Over the past 5 years, Capricor Therapeutics' Assets Average (Quarter) stood at $42.2 million in 2021, then grew by 23.2% to $52.0 million in 2022, then fell by 7.82% to $47.9 million in 2023, then soared by 174.73% to $131.7 million in 2024, then decreased by 1.3% to $130.0 million in 2025.
- Its Assets Average was $130.0 million in Q3 2025, compared to $143.7 million in Q2 2025 and $162.1 million in Q1 2025.